|
The customer observed falsely depressed total bilirubin results after a new wedge was put on the instrument.The customer noticed it when they started to get less than results on their patients.They recalibrated the assay and ran qc and qc came within range; they reran their patients and got actual results other than less than and had to make corrected reports.The following data was provided (patient reference range 0.2 - 1.3 mg/dl): sample id original result repeat result: (b)(6) 0.19 0.71, (b)(6) 0.1 0.23, (b)(6) 0.1 0.43, (b)(6) 0.65 1.14, (b)(6) 0.1 0.51, (b)(6) 0.1 0.32, (b)(6) 0.1 0.36, (b)(6) 0.1 0.36, (b)(6) 0.1 0.54, (b)(6) 0.1 0.3, (b)(6) 0.55 1.08, (b)(6) 0.1 0.45, (b)(6) 0.31 0.82, (b)(6) 0.1 0.3, (b)(6) 0.1 0.33, (b)(6) 0.24 0.75, (b)(6) 0.1 0.51, (b)(6) 0.12 0.62, (b)(6) 0.1 0.54, (b)(6) 0.1 0.63, (b)(6) 0.57 1.05, (b)(6) 0.1 0.26, (b)(6) 0.1 0.5, (b)(6) 0.1 0.28, (b)(6) 0.14 0.62, (b)(6) 0.33 0.85, (b)(6) 0.7 0.56, (b)(6) 0.5 0.39, (b)(6) 1.2 1.71, (b)(6) 0.4 0.25, (b)(6) 0.18 0.71, (b)(6) 0.34 0.85, (b)(6) 0.6 0.45, (b)(6) 0.5 0.38, (b)(6) 0.7 0.54, (b)(6) 0.1 0.42, (b)(6) 0.3 0.19, (b)(6) 0.1 0.45, (b)(6) 1 1.38, (b)(6) 0.2 0.49, (b)(6) 0.1 0.37, (b)(6) 0.3 0.65, (b)(6) 0.2 0.56, (b)(6) 0.9 1.27, (b)(6) 0.1 0.43, (b)(6) 0.2 0.51, (b)(6) 0.2 0.57, (b)(6) 0.6 0.95, (b)(6) 0.2 0.55, (b)(6) 0.5 0.89, (b)(6) 0.1 0.47, (b)(6) 0.1 0.38, (b)(6) 0.6 0.96, (b)(6) 0.6 0.96, (b)(6) 0.2 0.52, (b)(6) 0.2 0.49, (b)(6) 0.8 1.15.No impact to patient management was reported.
|